Encapsulate
PrivateLast Round
Grant
Jul 1, 2025
Total Funding Raised
$5.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Encapsulate is a biotechnology company that develops automated tumor-on-a-chip systems to provide personalized cancer therapy recommendations by testing treatments on patient-derived microtumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Encapsulate Comparables
Compare Encapsulate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xilis | 86% | |
| PreComb Therapeutics | 83% | |
| Kiyatec | 81% |
Encapsulate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2025 | ||||
| Grant | Jun 15, 2025 | ||||
| Seed | Nov 19, 2024 | ||||
| Grant | Nov 18, 2024 | ||||
| Grant | Mar 15, 2023 | ||||
Grant | May 15, 2022 |
Key People
Founding team and executive leadership
Encapsulate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Seed |
| Ambit Health Ventures | Seed |
| Entrepreneurship World Cup | Grant |
| Blackwood Healthcare Breakthroughs | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- Jul 18, 2026
Grew 23% QoQ, from 13 to 16 employees.
Encapsulate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Encapsulate's valuation, stock price, and market status.
Is Encapsulate a public or private company?
Encapsulate is a private company.
What is the current stock price of Encapsulate?
Encapsulate is a private company with no public stock price. No recent secondary market data is available.
How much is Encapsulate worth (valuation)?
Valuation information for Encapsulate is not publicly available.
Can I buy Encapsulate stock?
Encapsulate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Encapsulate's last funding round?
Encapsulate's most recent funding round was Grant on July 8, 2025.
Who are the main investors in Encapsulate?
Key investors in Encapsulate include Ambit Health Ventures, Entrepreneurship World Cup, Blackwood Healthcare Breakthroughs, National Science Foundation.
Will Encapsulate IPO soon?
No public IPO plans have been announced for Encapsulate.
How can I track Encapsulate secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Encapsulate's secondary market activity and sign up for updates.